原发性腮腺淋巴瘤的临床病理特点及预后分析  

Clinicopathological characteristics and prognostic analysis of primary parotid lymphoma

作　　者：杨璐 田大皓 陈玺 李晓洁[1] Yang Lu;Tian Dahao;Chen Xi;Li Xiaojie(Departmentof Pathology,Anhui Cancer Hospital,Hefei,Anhui,230031;Department of Pathology,Ma’anshan People's Hospital,Maa’anshan,Anhui,243000,China)

机构地区：[1]安徽省肿瘤医院,安徽合肥230031 [2]马鞍山市人民医院,安徽马鞍山243000

出　　处：《中国医学文摘（耳鼻咽喉科学）》2022年第6期134-135,133,共3页Chinese Medical Digest(Otorhinolaryngology)

摘　　要：目的分析PPL(原发性腮腺淋巴瘤)的临床病理特点及预后。方法入组研究对象是2019年4月~2021年4月收治的50例PPL患者,结合患者临床资料、复发随访资料,分析病理特点及预后。结果12例是MALT,占25.00%,9例是DLBCL,占18.75%,11例是FL,占22.92%,9例是LBL,占18.75%,9例是LL,占18.75%。50例患者44例完全缓解,占88.00%,5例疾病进展,占10.00%,1例部分缓解,占2.00%。随访2年,9例死亡,占18.00%。结论PPL患者及早通过放化疗及手术治疗,会提高存活率,改善预后。Objective To analyze the clinicopathological characteristics and prognosis of PPL(primary parotid lymphoma).Methods The enrolled study subjects were 50 patients with PPL admitted from April 2019 to April 2021.Combined with the clinical data and recurrence follow-up data,the pathological characteristics and prognosis were analyzed.Results 12 cases were MALT,accounting for 25.00%,9 cases were DLBCL,accounting for 18.75%,11 cases were FL,accounting for 22.92%,9 cases were LBL,accounting for 18.75%,and 9 cases were LL,accounting for 18.75%.44 cases of 50 patients had complete remission,accounting for 88.00%,5 cases of disease progression,accounting for 10.00%,and 1 case of partial remission,accounting for 2.00%.After 2 years of follow-up,9 cases died,accounting for 18.00%.Conclusion Early treatment of PPL patients with chemotherapy,radiotherapy and surgery will increase the survival rate and improve the prognosis.

关 键 词：原发性腮腺淋巴瘤 病理特点 预后 

分 类 号：R73[医药卫生—肿瘤]